COHANCE - Swing Trade Analysis with AI Signals
← Back to ListKey Parameters
⭐ Swing Trade Rating: 3.0
✅ Positive
Cohance Lifesciences exhibits a reasonable ROCE of 10.4% and a low debt-to-equity ratio, suggesting financial stability. The stock’s current price is relatively close to its high, offering potential for modest gains if the trend continues.
⚠️ Limitation
The significant Qtr Profit Variance (-66.8%) alongside a negative MACD reading indicates recent underperformance and volatility. Furthermore, the elevated P/E ratio of 64.5 suggests overvaluation relative to the industry average.
📉 Company Negative News
Recent news regarding a scheduled earnings call does not inherently suggest negative developments but highlights a potential for future information releases.
📈 Company Positive News
None found
🏭 Industry
The pharmaceutical sector is generally characterized by long-term growth and stability, though subject to regulatory changes and patent expirations. Many companies within this sector demonstrate consistent profitability despite cyclical pressures.
🧾 Conclusion
Considering the recent volatility and negative profit variance, an entry price around 380 ₹ would be prudent, aiming for a stop-loss order just below the 50 DMA at 431 ₹. A potential exit strategy is to monitor the MACD; if it shifts positively and breaks above 512₹, holding the position could prove beneficial, otherwise, reduce exposure around 400 ₹.